Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications
Jens Staal, Rudi Beyaert
Cells (2018) Vol. 7, Iss. 9, pp. 122-122
Open Access | Times Cited: 87

Showing 1-25 of 87 citing articles:

Anti-Cancer Effects of Green Tea Polyphenols Against Prostate Cancer
Yasuyoshi Miyata, Yohei Shida, Tomoaki Hakariya, et al.
Molecules (2019) Vol. 24, Iss. 1, pp. 193-193
Open Access | Times Cited: 117
Inflammation as a Driver of Prostate Cancer Metastasis and Therapeutic Resistance
Maddison Archer, Navneet Dogra, Natasha Kyprianou
Cancers (2020) Vol. 12, Iss. 10, pp. 2984-2984
Open Access | Times Cited: 99
Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer
Nurul Azwa Abd. Wahab, Nordin H. Lajis, Faridah Abas, et al.
Nutrients (2020) Vol. 12, Iss. 3, pp. 679-679
Open Access | Times Cited: 97
Potential Bioactive Components and Health Promotional Benefits of Tea ( Camellia sinensis )
Saptadip Samanta
Journal of the American Nutrition Association (2020) Vol. 41, Iss. 1, pp. 65-93
Closed Access | Times Cited: 83
AMPK activation protects against prostate cancer by inducing a catabolic cellular state
Lucy Penfold, Angela Woods, Alice Pollard, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112396-112396
Open Access | Times Cited: 24
The role of proinflammatory cytokines and CXC chemokines (CXCL1–CXCL16) in the progression of prostate cancer: insights on their therapeutic management
Amin Ullah, Jiao Wang, Bairong Shen
Cellular & Molecular Biology Letters (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 10
Prostate Cancer: A Journey Through Its History and Recent Developments
Hamza Mallah, Zania Diabasana, Sina Soultani, et al.
Cancers (2025) Vol. 17, Iss. 2, pp. 194-194
Open Access | Times Cited: 1
The Crosstalk between Prostate Cancer and Microbiota Inflammation: Nutraceutical Products Are Useful to Balance This Interplay?
Felice Crocetto, Mariarosaria Boccellino, Biagio Barone, et al.
Nutrients (2020) Vol. 12, Iss. 9, pp. 2648-2648
Open Access | Times Cited: 52
Advances and Perspectives in Prostate Cancer Biomarker Discovery in the Last 5 Years through Tissue and Urine Metabolomics
Ana Rita Lima, Joana Pinto, Filipa Amaro, et al.
Metabolites (2021) Vol. 11, Iss. 3, pp. 181-181
Open Access | Times Cited: 52
Green nanotechnology of MGF-AuNPs for immunomodulatory intervention in prostate cancer therapy
Menka Khoobchandani, Aslam A. Khan, Kavita Katti, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 47
Ginsenosides in cancer: Targeting cell cycle arrest and apoptosis
Muhammad Ajmal Shah, Syed Abuzar, Kainat Ilyas, et al.
Chemico-Biological Interactions (2023) Vol. 382, pp. 110634-110634
Open Access | Times Cited: 22
Prostate cancer microenvironment: multidimensional regulation of immune cells, vascular system, stromal cells, and microbiota
Lin Chen, Yuxin Xu, Yuanshuo Wang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Oxidative Stress and Redox-Dependent Signaling in Prostate Cancer
Elena Kalinina, Л. А. Гаврилюк, Vadim S. Pokrovsky
Biochemistry (Moscow) (2022) Vol. 87, Iss. 5, pp. 413-424
Closed Access | Times Cited: 27
Sirtuin 5 regulates the proliferation, invasion and migration of prostate cancer cells through acetyl‐CoA acetyltransferase 1
Jingqian Guan, Xizi Jiang, Junda Gai, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 23, pp. 14039-14049
Open Access | Times Cited: 36
Herb-target virtual screening and network pharmacology for prediction of molecular mechanism of Danggui Beimu Kushen Wan for prostate cancer
Hong Li, Andrew Hung, Angela Wei Hong Yang
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 29
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor Microenvironment
Andrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 22, pp. 12330-12330
Open Access | Times Cited: 28
Review: NF-kB activation in canine cancer
Lisa J. Schlein, Douglas H. Thamm
Veterinary Pathology (2022) Vol. 59, Iss. 5, pp. 724-732
Closed Access | Times Cited: 20
CRISPR/Cas9-mediated deletion of Interleukin-30 suppresses IGF1 and CXCL5 and boosts SOCS3 reducing prostate cancer growth and mortality
Carlo Sorrentino, Luigi D’Antonio, Stefania L. Ciummo, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 19
Strategies for the discovery of potential anticancer agents from plants collected from Southeast Asian tropical rainforests as a case study
Esperanza J. Carcache de Blanco, Ermias Mekuria Addo, Liva Harinantenaina, et al.
Natural Product Reports (2023) Vol. 40, Iss. 7, pp. 1181-1197
Closed Access | Times Cited: 12
Role of Metabolism and Metabolic Pathways in Prostate Cancer
Uddesh Ramesh Wanjari, Anirban Goutam Mukherjee, Abilash Valsala Gopalakrishnan, et al.
Metabolites (2023) Vol. 13, Iss. 2, pp. 183-183
Open Access | Times Cited: 11
Transcription Factors in Prostate Cancer: Insights for Disease Development and Diagnostic and Therapeutic Approaches
Karla Christina Sousa Silva, Nadine Tambwe, Dalia H. Mahfouz, et al.
Genes (2024) Vol. 15, Iss. 4, pp. 450-450
Open Access | Times Cited: 4
Ritonavir’s Evolving Role: A Journey from Antiretroviral Therapy to Broader Medical Applications
Mariana Pereira, Nuno Vale
Current Oncology (2024) Vol. 31, Iss. 10, pp. 6032-6049
Open Access | Times Cited: 4
MiRNAs and tempol therapeutic potential in prostate cancer: a preclinical approach
Isabela Maria Urra Rossetto, Letícia Ferreira Alves, Leonardo Augusto Marson, et al.
Journal of Molecular Histology (2025) Vol. 56, Iss. 1
Closed Access
Erioflorin and Erioflorin Acetate Induce Cell Death in Advanced Prostate Cancer Through ROS Increase and NF-κB Inhibition
Cecilia Villegas, Iván González‐Chavarría, Viviana Burgos, et al.
Journal of Xenobiotics (2025) Vol. 15, Iss. 2, pp. 45-45
Open Access
Melatonin augments anti-tumor activity and alleviates nephrotoxicity of gemcitabine in a pancreatic cancer xenograft model targeting P62/Keap1 pathway
Samar Ibrahim, Eman H. Yousef, Ahmed M. El‐Dessouki, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Open Access
Page 1 - Next Page

Scroll to top